| Outcomes of COVID-19 in patients with CLL: a multicenter international experience AR Mato, LE Roeker, N Lamanna, JN Allan, L Leslie, JM Pagel, K Patel, ... Blood, The Journal of the American Society of Hematology 136 (10), 1134-1143, 2020 | 308 | 2020 |
| Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia P Ouillette, K Saiya-Cork, E Seymour, C Li, K Shedden, SN Malek Clinical Cancer Research 19 (11), 2893-2904, 2013 | 79 | 2013 |
| A quantitative analysis of subclonal and clonal gene mutations before and after therapy in chronic lymphocytic leukemia NA Amin, E Seymour, K Saiya-Cork, B Parkin, K Shedden, SN Malek Clinical Cancer Research 22 (17), 4525-4535, 2016 | 74 | 2016 |
| COVID-19 in patients with CLL: improved survival outcomes and update on management strategies LE Roeker, TA Eyre, MC Thompson, N Lamanna, AR Coltoff, MS Davids, ... Blood, The Journal of the American Society of Hematology 138 (18), 1768-1773, 2021 | 59 | 2021 |
| Colony-stimulating factor-1 receptor is required for nurse-like cell survival in chronic lymphocytic leukemia A Polk, Y Lu, T Wang, E Seymour, NG Bailey, JW Singer, PS Boonstra, ... Clinical Cancer Research 22 (24), 6118-6128, 2016 | 57 | 2016 |
| Increasing incidence of Epstein‐Barr virus–related nasopharyngeal carcinoma in the United States I Argirion, KR Zarins, JJ Ruterbusch, P Vatanasapt, H Sriplung, ... Cancer 126 (1), 121-130, 2020 | 42 | 2020 |
| Real‐world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis EK Seymour, JJ Ruterbusch, JL Beebe‐Dimmer, CA Schiffer Cancer 125 (1), 135-143, 2019 | 26 | 2019 |
| Selinexor in combination with R-CHOP for frontline treatment of non-hodgkin lymphoma: results of a phase I study EK Seymour, HY Khan, Y Li, M Chaker, I Muqbil, A Aboukameel, ... Clinical Cancer Research 27 (12), 3307-3316, 2021 | 23 | 2021 |
| Investigational CD47-blocker TTI-622 shows single-agent activity in patients with advanced relapsed or refractory lymphoma: update from the ongoing first-in-human dose … K Patel, R Ramchandren, M Maris, AM Lesokhin, GR von Keudell, ... Blood 136, 46-47, 2020 | 22 | 2020 |
| Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells ML Palomba, K Piersanti, CGK Ziegler, H Decker, JW Cotari, K Bantilan, ... PLoS One 9 (1), e79987, 2014 | 20 | 2014 |
| The DISCO app: a pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication LM Hamel, DW Dougherty, TA Hastert, EK Seymour, S Kim, H Assad, ... PEC innovation 1, 100002, 2022 | 13 | 2022 |
| Incorporating value-based care into oncology EK Seymour, JA de Souza, AM Fendrick The Cancer Journal 26 (4), 311-322, 2020 | 13 | 2020 |
| Polatuzumab vedotin (Pola)+ rituximab (R)+ lenalidomide (Len) in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Primary analysis of a … CS Magid Diefenbach, P Abrisqueta, E Gonzalez-Barca, C Panizo, ... Journal of Clinical Oncology 39 (15_suppl), 7512-7512, 2021 | 9 | 2021 |
| The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States EK Seymour, JJ Ruterbusch, AN Winn, JA George, JL Beebe‐Dimmer, ... Cancer 127 (1), 93-102, 2021 | 9 | 2021 |
| Ongoing, first-in-human, phase I dose escalation study of the investigational CD47-blocker TTI-622 in patients with advanced relapsed or refractory lymphoma. K Patel, MB Maris, BD Cheson, JA Zonder, AM Lesokhin, G Von Keudell, ... Journal of Clinical Oncology 38 (15_suppl), 3030-3030, 2020 | 8 | 2020 |
| Challenges in the clinical application of the American Society of Clinical Oncology Value Framework: a Medicare cost-benefit analysis in chronic lymphocytic leukemia EK Seymour, CA Schiffer, JA de Souza Journal of oncology practice 13 (12), e1002-e1011, 2017 | 6 | 2017 |
| The COVID-19 pandemic and in-person visit rate disruptions among patients with hematologic neoplasms in the US in 2020 to 2021 G Goyal, KW Lau, X Wang, AJ Davidoff, SF Huntington, O Jamy, G Calip, ... JAMA Network Open 6 (6), e2316642-e2316642, 2023 | 5 | 2023 |
| Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the … G Goyal, T Magnusson, X Wang, J Roose, M Narkhede, E Seymour Haematologica 108 (4), 1190, 2023 | 5 | 2023 |
| How to effectively decrease patient co-payments of high-cost drugs through innovation: Lessons from the Karmanos specialty pharmacy EK Seymour, L Daniel, E Pointer, J Julian, ST Smith, CA Schiffer JCO Oncology Practice 18 (1), e137-e151, 2022 | 5 | 2022 |
| Worldwide examination of patients with CLL hospitalized for COVID-19 LE Roeker, L Scarfo, T Chatzikonstantinou, P Abrisqueta, TA Eyre, ... Blood 136, 45-49, 2020 | 5 | 2020 |
